trending Market Intelligence /marketintelligence/en/news-insights/trending/qRv6kjG0cya0lHNZc9xfng2 content esgSubNav
In This List

Cynata Therapeutics completes A$6M capital raising

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Cynata Therapeutics completes A$6M capital raising

Cynata Therapeutics Ltd. completed a placement of about 9.23 million fully paid ordinary shares at 65 Australian cents apiece, for gross proceeds of A$6.0 million before costs.

The oversubscribed placement was made to both new and existing institutional investors, Cynata said. The placement is expected to occur on or about Jan. 27, and the shares to be issued Jan. 30.

Cynata plans to use proceeds along with its FUJIFILM Corp. investment to accelerate and expand the development of Cymerus, its therapeutic mesenchymal stem cell technology.

The placement was jointly managed by Shaw and Partners Ltd. and CPS Capital Group Pty Ltd.

As of Jan. 20, US$1 was equivalent to A$1.32.